Literature DB >> 9928762

Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization.

N Kobayashi1, M Ishii, Y Ueno, N Kisara, N Chida, T Iwasaki, T Toyota.   

Abstract

AIMS/
BACKGROUND: Transcatheter arterial chemoembolization (TAE) of hepatocellular carcinoma (HCC) causes anoxia. Escape of cancer cells from anoxic injury may be enhanced by induction of proteins which provide resistance to apoptosis.
METHODS: We examined HCCs immunohistochemically for Bcl-2, vascular endothelial growth factor (VEGF), p53, and Ki67. The staining intensity for VEGF, a protein induced by anoxia, was assessed morphometrically with a computer-assisted image-analyzer.
RESULTS: The frequency of Bcl-2 positive cells was higher in HCCs that had undergone TAE (TAE HCC) than that in HCCs that had not undergone TAE (41.75+/-15.06 vs. 1.01+/-0.79 cells/1000 cells, p = 0.0173). The frequency of p53- or Ki67-positive cells was not increased after TAE. Of 12 TAE HCCs, 7 had Bcl-2 positive HCC cells and 6 had clusters of Bcl-2 positive cells. In contrast, 2 of 11 HCCs that had not undergone TAE had only a few, sporadically distributed, Bcl-2-positive cells. The staining intensity for VEGF was higher in Bcl-2 positive than in Bcl-2 negative areas (1.208+/-0.091 vs. 1.071+/-0.017, p = 0.0222). Furthermore, the VEGF staining intensity in Bcl-2 positive areas of TAE HCCs was higher than in Bcl-2 negative areas (1.296+/-0.126 vs. 1.066+/-0.024, p = 0.0186), while in HCCs that had not undergone TAE the staining intensity was similar.
CONCLUSIONS: TAE of HCC can induce Bcl-2 expression, possibly through anoxic stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9928762     DOI: 10.1111/j.1478-3231.1999.tb00005.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  23 in total

1.  Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?

Authors:  G Cox; R A Walker; S Muller; K R Abrams; W P Steward; K J O'Byrne
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.

Authors:  J Yi; X Liao; Z Yang; X Li
Journal:  J Tongji Med Univ       Date:  2001

3.  Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.

Authors:  Y Nakamoto; E Mizukoshi; H Tsuji; Y Sakai; M Kitahara; K Arai; T Yamashita; K Yokoyama; N Mukaida; K Matsushima; O Matsui; S Kaneko
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 4.  Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.

Authors:  Jonathon Willatt; Kevin K Hannawa; Julie A Ruma; Timothy L Frankel; Dawn Owen; Pranab M Barman
Journal:  World J Hepatol       Date:  2015-02-27

5.  [Transarterial ablation of hepatocellular carcinoma. Status and developments].

Authors:  B A Radeleff; U Stampfl; C M Sommer; N Bellemann; K Hoffmann; T Ganten; R Ehehalt; H U Kauczor
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

6.  Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.

Authors:  Shih-Ho Wang; Li-Mien Chen; Wen-Kai Yang; Jane-Dar Lee
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

7.  Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.

Authors:  Pi-Yi Chang; Chun-Chieh Huang; Chao-Hung Hung; Chih-Yung Yu; Ding-Kwo Wu; Jen-I Hwang; Po-Chin Liang; Reng-Hong Wu; Wei-Lun Tsai; Yih-Jyh Lin; Yi-Sheng Liu; Huei-Lung Liang; Rheun-Chuan Lee; Chien-Hung Chen
Journal:  Liver Cancer       Date:  2018-03-29       Impact factor: 11.740

Review 8.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.

Authors:  Thomas Josef Vogl; Jun Qian; Andreas Tran; Elsie Oppermann; Nagy N Naguib; Huedayi Korkusuz; Nour Eldin A Nour Eldin; Wolf Otto Bechstein
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

10.  Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study.

Authors:  Akira Mizuki; Masayuki Tatemichi; Nobuhiro Tsukada; Ryousuke Nagamatsu; Mitsuhiko Kawaguchi; Tatsuya Itoshima; Shigeki Maruyama; Atsuhiko Satou; Yasuhisa Imari; Toshiharu Kawatoko; Junya Shimono; Hiroshi Nagata
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.